EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

New data obtained has found cases soared over the four weeks to the end of November, with an extra 118 hospitalisations ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

A recent study published in JAMA Psychiatry has uncovered promising evidence suggesting that glucagon-like peptide-1 (GLP-1) ...